Skyline Therapeutics Presents Late-Breaking Abstract on SKG1108, a Novel Optogenetic Gene Therapy for Retinitis Pigmentosa, at ASGCT 2025 ...Middle East

SHANGHAI, May 10, 2025 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven clinical-stage gene therapy company focused on developing unique and novel solutions for rare and severe diseases, today announced a late-breaking abstract presentation on SKG1108, its investigational...

Read More Details
Finally We wish PressBee provided you with enough information of ( Skyline Therapeutics Presents Late-Breaking Abstract on SKG1108, a Novel Optogenetic Gene Therapy for Retinitis Pigmentosa, at ASGCT 2025 )

Also on site :

• BetMGM Bonus Code NW150: Get Latest $150 Bonus for NBA, NHL, UFC 315
• LSU sees 4-star 2026 WR flip commitment to SMU
• 43 Mother's Day Dessert Recipes to Satisfy Every Type of Sweet Tooth